INTRODUCTION
Long-term immunity relies on memory cells providing protection against recurring infections. The shaping of functional features of memory cells during primary reactions includes the imprinting of migration properties that secure their optimal targeting to potentially affected compartments. This topographical memory, described as organ-specific homing more than 50 years ago, 1 was a well-accepted paradigm that appeared to be supported by a number of studies on gutand skin-specific homing of T memory cells (T mem ) generated in site-specific immune responses. [2] [3] [4] Homing of T cells into distinct tissues depends on the expression of adhesion molecules and chemokine receptors. Naive CD4 þ T cells (T N ) uniformly recirculate through secondary lymphoid organs via L-selectin and CCR7, a behavior preserved by early stages of T mem . However, upon further differentiation, T cells home preferentially into peripheral tissues such as the skin and gut or into inflamed sites. Eventually, part of the cells will become tissue-resident cells that stop circulating. 5, 6 In this study, we investigated the stability and molecular regulation of integrin a 4 b 7 -dependent mucosa-specific homing of CD4 þ T mem from lymphoid tissues that largely belong to the recirculating pool of CD4 þ T mem . T cells homing to skin express E-and P-selectin ligands and the chemokine receptor CCR4 and/or CCR8. By contrast, guthoming T mem selectively express the integrin a 4 b 7 and partially express the chemokine receptor CCR9, enabling their entry into the intestine and associated lymphoid tissues by interacting with the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and the chemokine CCL25, respectively. [7] [8] [9] Expression of these receptors is de novo induced or upregulated upon antigeninduced activation within mesenteric lymph nodes (mLNs) or Peyer's patches. 10 The vitamin A metabolite retinoic acid (RA), provided by CD103 þ dendritic cells (DCs) and/or stromal cells in mLNs, 11, 12 has been identified as a crucial factor together with T-cell activation for induction of a 4 b 7 and CCR9. 13 Notably, the assumption of the homing paradigm that T mem cells acquire a stable homing phenotype by imprinted expression of a given set of adhesion receptors in CD4 þ T mem only has been proven experimentally for selectin ligands so far. 14, 15 In fact, recent studies in CD8
þ T cells have rather demonstrated that the mucosal homing receptor a 4 b 7 is only transiently expressed on CD8 þ T cells and that a 4 b 7 þ gut-homing CD8 þ T cells might convert into a skin-homing phenotype. [16] [17] [18] This implied plasticity of migratory phenotypes and the possibility that certain homing phenotypes require continuous stimulation by environmental signals to be maintained.
In the first part of this study, we therefore investigated whether CD4
þ T mem retain expression of the gut-homing receptor a 4 b 7 in vivo or upon restimulation in vitro, or whether continuous instruction by tissue-localized factors is required for the maintenance of gut-homing properties. Indeed, ex vivo isolated a 4 b 7 þ CD4 þ T mem maintained their initial a 4 b 7 expression level independent of the presence of RA or other environmental factors encountered during recirculation through gut or gut-associated lymphoid tissues (GALTs). To acquire a stable phenotype, repeated stimulation of T N cells in the presence of RA was required, suggesting a stepwise acquisition of an imprinted state.
In a second part, we analyzed the molecular basis for the imprinted phenotype. The regulation of a 4 -integrins is not well understood, despite significant medical relevance of a 4 -integrins as a target for antibody therapies in chronic inflammatory bowel disease and multiple sclerosis.
Here we focused on the role of epigenetic mechanisms, as a growing list of evidence suggests that DNA methylation or histone modifications might be the key for a stably imprinted expression pattern in polarized T-helper (Th) subsets, stable lineages such as regulatory T cells, expression of signature cytokines, or master transcription factors. [19] [20] [21] [22] Albeit it appears suggestive, homing receptors have hardly been analyzed in this respect so far.
While some histone modifications appear to be solely associated with current transcriptional activity, notably DNA methylation and other repressive mechanisms are key candidates for the regulation of a long-term, heritable phenotype. 23 We therefore analyzed the DNA methylation patterns of the Itga4 locus-coding for the integrin a 4 chain-in murine and human T cell subsets. Indeed, differential DNA methylation was observed in distinct regulatory regions and appears to control the stability of Itga4 expression. Figure 1A online) with CFSE, transferred them into recipient mice and reanalyzed a 4 b 7 expression on transferred cells 15 days (Figure 1a and b) or 6 weeks later ( Figure 1c) Figure 1A and B) , which coexpress other homing receptors such as L-selectin (CD62L). L-selectin controls pLN immigration and is likely to cause enrichment of the CD62L þ fraction at this site.
RESULTS
Stable expression of a 4 b 7 on murine CD4 þ T mem depends neither on stabilizing factors within the GALT nor on the presence of RA The observed in vivo stability could be mediated either by a cellintrinsic imprinting of a 4 b 7 expression or by continual encounter with environmental signals required for its maintenance. As a 4 b 7 is induced by the vitamin A metabolite RA, 13 we asked whether the maintained expression of a 4 b 7 in vivo depends on the presence of RA.
To investigate this question, we generated vitamin A-deficient mice by pre-and postnatal feeding of a vitamin A-deficient diet for at least 14 weeks and used them as recipients for adoptive transfer of a 4 b 7 þ and a 4 b 7 À CD4 þ T mem . As shown in Figure 2a , the expression of a 4 b 7 on transferred CD4 þ T mem was not affected by vitamin A deficiency. By contrast, endogenous T cells displayed low levels of a 4 b 7 under these conditions (Figure 2a) , and naive OVA-specific CD4 þ T cells transferred into vitamin A-deficient mice failed to upregulate a 4 b 7 and CCR9 upon oral application of OVA protein and cholera toxin (Figure 2b) . This proved the effective removal of RA from the system. The data indicate that while RA is critical for the de novo induction of a 4 b 7 , it is not required for the maintenance of a 4 b 7 on CD4 þ T mem . T mem residing in secondary lymphoid tissues are known to recirculate to some extent between blood, lymph, and tissues. 24, 25 We therefore asked whether local factors in the gut or GALT were required for the stability of a 4 b 7 expression in CD4 þ T mem . To prevent access of CD4 þ T mem to mucosal sites, we blocked the adhesion molecules MAdCAM-1 and vascular cell adhesion molecule-1 (VCAM-1) involved in the entry of lymphocytes into this compartment by injection of antiMAdCAM-1 and anti-VCAM-1 antibodies. This treatment reduced the entry of CD4 þ T mem into both gut and GALT by 85-95% (Supplementary Figure 2) . To examine whether the maintenance of a 4 b 7 expression depends on gut-derived instructive signals, we transferred a 4 b 7 þ CD4 þ T mem into recipient mice together with injection of either anti-MAdCAM-1 plus anti-VCAM-1 antibodies or a rat-immunoglobulin G (IgG) control antibody. Antibody treatment was repeated every 3 days until analysis on day 15, resulting in the exclusion of transferred CD4
þ T mem from the gut and GALT and their accumulation in the spleen (Figure 2c 
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Control recipient We tested ex vivo sorted a 4 b 7 þ CD4 þ T mem for their phenotypic stability in in vitro cultures and observed that they largely retained a 4 b 7 expression upon restimulation (Figure 3a) , confirming the imprinted state of a 4 b 7 in memory cells. Notably, expression was retained not only in the absence of RA but also in the presence of interleukin-12 (IL-12), which is known to upregulate the competing homing receptors P-and E-selectin ligands (''skin-homing phenotype''). 26, 27 Selectin ligands are expressed in T mem , but, for ex vivo isolated cells, in a largely mutually exclusive way to a 4 b 7 (see Figure 6 and Supplementary Figure 1) .
Besides a 4 b 7 , the chemokine receptor CCR9 is also induced by RA. CCR9 is thought to have a role in the immigration of cells to the small intestine; however, in accordance with previous reports, 16 only a small fraction of-mostly a 4 b 7 þ -CD4 þ T mem from mLNs and spleen express this receptor. When ex vivo-sorted CCR9 þ T mem were stimulated in vitro, CCR9 was almost completely lost in the absence but retained in the presence of RA (Figure 3b ), suggesting that CCR9 is not imprinted in CD4
þ T mem but requires continual RA signals from the environment to remain expressed. These data add further evidence to previous findings, suggesting that the regulation of the gut-homing receptors a 4 b 7 and CCR9 differs.
28,29
Repetitive, but not single, stimulation in the presence of RA stabilizes a 4 b 7 expression a 4 b 7 Expression can be induced in CD4 þ T cells by RA, but it is unclear whether this is sufficient to achieve stable a 4 b 7 expression as found in CD4 þ T mem . Therefore, we induced Cell-intrinsic imprinting of a given gene activity state often relies on mechanisms of epigenetic regulation such as DNA methylation of critical genomic elements. We therefore performed a pilot MeDIP-on-Chip experiment to search for potential differentially methylated regions in the Itga4 and Itgb7 loci in ex vivo a 4 b 7 þ vs.
þ T mem subsets (data not shown). Differential methylation was apparent in two regions in the Itga4 locus: the Itga4 promoter upstream of the transcription start site containing a CpG-island (CpG-I), and a region in the second intron, which we termed differentially methylated region 1 (dmr1), both containing several CpG motifs ( Figure 5a ). No dmr were observed in the Itgb7 locus. In line with previous reports, 30 we found only Itga4, but not Itgb7, to be regulated by repetitive RA treatment (Supplementary Figure 3) . For these reasons, we focused our efforts on clarifiying the mechanism for the stability of a 4 b 7 expression on the Itga4 locus.
We tested both regions in the Itga4 gene for their regulatory activity on transcription using a classic luciferase reporter assay in murine CD4 þ T cells (Figure 5b and c). As expected, the Itga4 promoter (but not dmr1; Figure 5b ) was able to induce expression of the luciferase reporter, whereas the dmr1 element displayed an enhancer function when tested in conjunction with a promoter (Figure 5c ). 
low T cells were stimulated with plate-bound anti-CD3/ 28 antibodies and interleukin-2 (IL-2) in the presence or absence of retinoic acid (RA) (1 nM) and IL-12 (5 ng ml À 1 ). On day 5, cells were harvested and analyzed for homing receptor expression by flow cytometry. Some unstained cells (lower left quadrant) were added in the staining control to facilitate compensation.
were stimulated with plate-bound anti-CD3/28 antibodies and IL-2 in the presence or absence of RA (0.1 and 1 nM). On day 5, cells were analyzed for a 4 b 7 and CCR9 expression. FACS (fluorescence-activated cell sorter) plots are representative of three independent experiments each performed in (a) triplicates or (b) duplicates.
Next, we designed amplicons on both regions to analyze the methylation status in CD4
þ T cells. As the promoter contained a large CpG-I, which was largely demethylated (data not shown), we concentrated our analysis on two CpG motifs in the CpG-I shore. Shores of CpG-I have been reported to contain most of the dynamic methylation-dependent regulatory capacity, whereas CpG-Is are usually uniformly demethylated in most promoters. 31 Indeed, we found significant demethylation of the two CpG-I shore CpGs in a 4 b 7 þ CD4 þ T mem as well as in T cells repeatedly stimulated in the presence of RA (Figure 5d) . Their a 4 b 7 À counterparts (a 4 b 7 À P-lig þ T mem , expressing the inflammation/skin-related homing receptor P-selectin ligand (P-lig), as well as T cells stimulated in the presence of the RA antagonist LE540), displayed high methylation levels. Interestingly, ex vivo-isolated T N cells, which have not yet undergone imprinting for a certain homing phenotype, showed an equally low degree of methylation, suggesting that these cells are permissive for the expression of a 4 b 7 in the presence of appropriate conditions, whereas stimulation in the absence of RA signaling or differentiation into skin-homing T mem promotes acquisition of an inhibitory epigenetic mark at the promoter.
Analysis of seven CpGs in dmr1 showed a significant demethylation in a 4 b 7 þ vs. a 4 b 7 À CD4 þ T mem , whereas RAinduced a 4 b 7 þ T cells displayed only small differences from their counterparts treated with the RA antagonist LE540 or uncommited T N cells (Figure 5e ). These data indicate that the methylation level in dmr1 qualifies as a stabilizer for Itga4 expression in fully imprinted a 4 b 7 þ CD4 þ T mem , whereas repetitive stimulation in vitro in the presence of RA might not be sufficient to achieve full epigenetic fixation at this regulatory element. As further support for this conclusion, we found increased stability of a 4 b 7 expression in murine T N , which were treated with the DNA-demethylating drug 5-azacytidine during the RA-mediated induction phase (Supplementary Figure 4) .
To confirm the putative methylation-dependent enhancer/ stabilizer function of dmr1, we cloned the dmr1 into a CpG-free luciferase reporter 32 -which allows selective in vitro methylation of inserted CpG-containing sequences-and performed reporter gene assays in primary murine T cells. Indeed, the enhancer activity of dmr1 was strongly compromised upon methylation (Figure 5c ), supporting a functional link between DNA methylation and transcriptional activity.
The human ITGA4 gene also shows epigenetic modification in
The murine Itga4 and human ITGA4 loci show a high degree of structural similarity (Figure 6a ) even if the sequence homology is variable. Therefore, similar regulatory mechanisms might apply. Using whole-genome bisulfite sequencing data of human CD4 þ T cells generated in the context of the German Epigenome Programme ''DEEP'', 33 we analyzed the ITGA4 promoter and searched for regions that were differentially methylated between naive and memory cells and might correspond to the murine dmr1. Two DMR were identified for which amplicons for the detailed analysis of DNA methylation were designed (Figure 6a expression is mutually exclusive to expression of the skinhoming receptor and E-selectin ligand CLA (Figure 6b ). In the naive fraction of human CD4 þ cells, both a 4 b 7 þ and a 4 b 7 À cells can be detected using the very bright Act-1-PE antibody (Figure 6b) , a finding of unknown biological significance that was not reported before and is not observed in murine cells. (Figure 6b) . We analyzed the degree of DNA methylation for six CpGs in the CpG-I shore of the promoter as well as for DMR1 and DMR2.
Methylation of the analyzed CpGs in the CpG-I shore of the promoter was generally at a low level, but lowest in the a 4 b 7 -expressing populations of both T N and T mem cells (Figure 6c and f). As observed in murine cells, the highest methylation was found in a 4 b 7 À (and CLA þ ) memory cells, suggesting an epigenetic silencing of ITGA4 during differentiation into skinhoming T mem . a 4 b 7 À -naive T cells displayed an intermediate methylation state, suggesting that they are predisposed to ITGA4 expression upon appropriate signaling.
For DMR1, fully commited a 4 b 7 þ CLA À T mem were the only cell type displaying consistently low levels of methylation among the CpGs of this region, indicating that DMR1 might serve as a stabilizer element (Figure 6d and f) . The a 4 b 7 þ fraction of T N showed a tendency towards decreased methylation compared with the a 4 b 7 À cell types, which, however, lacked statistical significance.
Interestingly, the methylation pattern in DMR2 discriminated T mem from T N , but was not correlated to a 4 b 7 expression (Figure 6e and f) . This suggests that epigenetic opening of this putative regulatory region might already occur with acquisition The Itga4 promoter and the dmr1 region were cloned into the promoter-free pGL3 luciferase reporter plasmids (pGL3-basic) and tested for transcriptional promoter activity in murine CD4 þ Th1 cells in a luciferase reporter assay. In addition, dmr1 was tested in a CpG-free luciferase reporter vector (pCpGL-hEF1) containing the hEF1 promoter. This vector allows application of in vitro methylation (and mock methylation as control), as this affects only the cloned insert. (c) With this approach, the methylation sensitivity of the enhancer function of dmr1 was assessed in primary murine CD4 þ T cells. (d and e) The degree of DNA methylation of selected CpG motifs (shown in a as black needle heads) in the (d) Itga4 promoter and (e) dmr1 was analyzed by bisulfite sequencing of T N (n ¼ 2) and ex vivo isolated a 4 b 7 þ or a 4 b 7 À P-lig þ T mem (n ¼ 3 each), as well as of cultured T N after two rounds of retinoic acid (RA) or LE540 treatment followed by a final round in the absence of both additives (N) (n ¼ 3 each). Mean ( ± s.d., if n42) methylation values for each CpG motif are given. Statistical significance of differences between all analyzed CpG motifs of the respective cell types in a given region was tested as described in the Method section. Significant differences are indicated: ***Po0.001 and NS, not significant. TSS, transcription start site. of a memory state and might allow for expression of ITGA4 also under conditions, where the a 4 -chain, but not the mucosaspecific a 4 b 7 -integrin is expressed. This would contrast to the role of dmr1/DMR1, which seems to regulate the a 4 -chain only in the mucosa-seeking subset of T mem . In addition, decreased methylation in three regions correlating with upregulated expression in T mem cells was also found for ITGB1, coding for the b1-integrin chain (Supplementary Figure 6) .
DISCUSSION
The differentiation of T-lymphocytes into memory cells is accompanied by functional specialization, including the acquisition of organ-specific homing capabilities. The present study was designed to answer the question whether, and if so which, cell-intrinsic mechanisms allow T cells primed under appropriate conditions to develop a stable topographical memory for the gut, independent of environmental signals. Our present data demonstrate that indeed an ''imprinting for gut homing'' is observed for the a 4 b 7 -integrin, which requires repetitive instruction by RA signals. In contrast, stable expression is not inducible for CCR9, at least under the conditions tested here. At the molecular level, this imprinting is based on epigenetic mechanisms, notably regulation of DNA (CpG À ) methylation at specific regulatory regions of the Itga4 locus.
The mucosal homing receptor a 4 b 7 integrin is expressed at a low, but functional, level on murine naive lymphocytes and enables their recirculation through gut-associated lymphoid tissues. 34 Upon activation and differentiation into effector/ memory cells, the population splits up into T mem that are either completely negative or highly positive for a 4 b 7 , the latter being considered as a stable mucosa-specific memory population. 10, 35 In contrast, Mora et al. 16 studied the expression of a 4 b 7 in CD8 þ T cells and reported a high degree of plasticity, as freshly generated a 4 b 7 þ CD8 þ T cells could be converted into a 4 b 7 À cells by restimulation in the presence of subcutanous instead of mucosal DCs, in line with other reports 18 . Moreover, these authors noted that ex vivo-isolated
were also found to change their a 4 b 7 expression pattern upon restimulation with the opposite type of DC, suggesting a lack of a 4 b 7 stability in CD8 þ T mem . More recently, Masopust et al. 17 observed in a comprehensive study a similar instability of a 4 b 7 expression on CD8 þ T cells in vivo. In addition, they found that a 4 b 7 was efficiently but only transiently upregulated upon in vivo activation, regardless of the site of antigen contact.
With these data, the original paradigm of organ-specific homing 1, 36 was questioned. We now demonstrate that CD4 þ T cells, in contrast, can acquire long-term stability of a 4 b 7 expression and hence mucosa-specific homing, restoring the validity of the homing concept for this subset. In fact, differences in the migratory program of CD4 þ and CD8 þ T mem including higher stability of selectin ligands on CD4 þ T mem have already been reported 15 and are now further corroborated by our present data.
RA, produced from the precursor vitamin A by stromal cells, 11, 37 CD103 þ DCs 13, 38 in gut-associated lymphoid tissues, or by liver sinusoidal cells, 39 is the key inducer of a 4 b 7 by regulating the a 4 -chain. 30 In contrast, basic levels of the b 7 -chain are constitutively transcribed in CD4 þ T cells, outcompeted by high levels of the b 1 -chain and regulated by tumor growth factor-b. 30, 40 We have shown here that RA signals are sufficient to induce a 4 b 7 expression, but the stability of expression (in the absence of RA) is not immediately achieved. Two rounds of in vitro activation in the presence of RA induced a certain degree of stability, yet complete stability with sustained high expression of a 4 b 7 was found only in ex vivo-isolated T mem .
Stability in vivo may rely on cell-intrinsic mechanisms, but, alternatively, may be caused by continuous exposure to RA according to three different scenarios: (i) exposure to low levels of RA within the circulation; 41 (ii) contact with RA-generating antigen-presenting cells during passage through the liver; 39 (iii) by recirculation through mucosal tissues harboring dendritic cells and/or stromal cells providing RA and/or other unknown instructive signals. However, a 4 b 7 expression was neither lost upon transfer into RA-depleted animals nor reduced when recirculation of transferred cells through mucosal tissues was blocked. Thus, the findings of this study strongly argue for cell-intrinsic mechanisms being responsible for the imprinting of the mucosal homing phenotype.
How could stability be achieved at a molecular level? A growing body of evidence assigns a key role to the epigenetic machinery in the fixation of phenotypic profiles, as shown for various processes of cell differentiation and lineage commitment. 20, 33, 42 In T cells, effector cytokines, master transcription factors and other genes are subject to epigenetic fixation 21, 22 and some indirect hints from our previous work also pointed towards a role in the regulation of homing. 14, 43 In particular, DNA methylation at promoters or enhancers appears to be an attractive mechanism for the regulation of cellular memory by control of chromatin accessibility and transcription factor binding, particularly with respect to the heritability of DNA methylation patterns during mitosis. 44 The results reported here provide first evidence that stable expression of a 4 b 7 in the absence of the initial inducer is indeed due to epigenetic regulation at the level of DNA methylation. In both murine and human CD4 þ T cells, the Itga4/ITGA4 locus was found to display distinct differentially methylated regions (dmr/DMR) whose degree of methylation correlated with a 4 b 7 expression, commitment, and/or memory differentiation.
First, several CpGs upstream of the promoter-associated demethylated CpG-I showed distinct differences in methylation. In murine T N , which express a low but detectable level of a 4 b 7 , 35 the two CpG upstream of the CpG-I were completely demethylated similar to the a 4 b 7 þ fraction of T mem . Although cells repeatedly stimulated in the presence of RA kept this status, stimulation in the absence of RA as well as in vivo differentiation into a 4 b 7 À T mem resulted in a pronounced methylation. Thus, we conclude that the open conformation of this region enables transcription in both T N and T mem , which, however, seems to be modulated by further regulatory regions, and can be silencend upon differentiation into non-mucosal subsets of T mem . It has to be mentioned that the degree of methylation was not uniform among the CpGs analyzed. Whether this relates to specific functions of single CpGs, e.g., by being part of a distinct transcription factor-binding motif, remains to be investigated. In human cells, for which an a 4 b 7 þ as well as an a 4 b 7 À population can be discriminated among T N , the latter show moderate methylation, whereas the positive fraction is significantly less methylated. Methylation levels in a 4 b 7 À T mem are much higher than in the a 4 b 7 þ T mem fraction. Thus, the suggested regulatory role of CpG methylation in the promotor-associated region seems to be conserved between mouse and man and to extend to subfractions of naive cells.
Second, differential methylation helped us to identify a novel regulatory region (dmr1) in the murine Itga4 locus that acts as an enhancer. In contrast to the promotor-associated region, the CpG motifs within dmr1 are almost completely methylated in T N , and there is only a minor, nonsignificant decrease of methylation upon repeated stimulation in the presence of RA, or in a 4 b 7 þ vs. a 4 b 7 À T N . However, the methylation level was strongly reduced in a 4 b 7 þ T mem as compared with a 4 b 7 À T mem or T N . The enhancer activity of dmr1 was completely abolished by artificial methylation, supporting the functional relevance of DNA methylation in controlling this region. A further hint at the functional role of DNA methylation on regulation of a 4 b 7 þ expression is the stabilizing effect of 5-azacytidine, which blocks DNA methylation; however, indirect effects of this genome-wide-acting inhibitor cannot be excluded.
A related site designated as DMR1 was identified in human CD4 þ T cells, which showed a corresponding demethylation signature correlating to a 4 b 7 þ expression. As an additional indication for a conserved mechanism of regulation via dmr1/DMR1, we found the activating histone modification mark H3K4me1 at the human DMR1, indicating that indeed it may serve as an enhancer element (Supplementary Figure 5) .
Recently, the transcription factor BATF has been reported to regulate the expression of the a 4 -chain in CD4 þ cells. 45 According to the ENCODE data, 46 BATF binds in a lymphoid cell line at the promoter region; further binding sites for BATF are predicted at the ITGA4 locus including at the DMR1 (using tRap and the jaspar database; data not shown), suggesting BATF as one possible transcription factor involved in a 4 b 7 stability.
Whole-genome bisulfite sequencing data of the human ITGA4 locus uncovered an additional DMR (DMR2). Similar to dmr1/DMR1, CpGs 1-5 were almost completely methylated in both a 4 b 7 þ -and a 4 b 7 À -naive cell subsets, but a highly significant drop in methylation was observed in both memory subsets. Here the differences between a 4 b 7 þ and a 4 b 7 À were less prominent and did not reach statistical significance. Hence, this region might be required for expression of the a 4 -chain in T mem in general (e.g. in a 4 b 1 þ , but a 4 b 7 À cells), but additional signals (e.g., from the dmr1/DMR1 enhancer) might regulate it in the mucosa-specific subset.
A subset of effector/memory T cells expresses the related integrin dimer a 4 b 1 (''VLA-4''). a 4 b 1 but not a 4 b 7 has a key role in multiple sclerosis as this integrin is essential for pathogenic T cells to cross the blood-brain barrier 47, 48 À T mem cells. Moreover, first evidence that the ITGB1 locus for his part is also regulated by epigenetic mechanisms can be deduced from the differential methylation in several regions of the human ITGB1 gene correlating with differential expression in T N vs. T mem (Supplementary Figure 6) .
In conclusion, the data of this study confirm the validity of the concept of a topographical memory in CD4 þ T mem and provide first evidence that the imprinting of a mucosa-specific homing phenotype involves epigenetic regulation of expression of the a 4 -integrin chain.
METHODS
Mice. C57Bl/6 and congenic Thy1.1 C57Bl/6 mice were bred at the Bundesinstitut fuer Risikobewertung (Berlin, Germany) and were used at 8-12 weeks of age. BALB/c mice and 7-9-month-old exbreeders were from Charles River WIGA GmbH (Sulzfeld, Germany). All animal experiments were performed under specific pathogen-free conditions and in accordance with institutional, state, and federal guidelines as approved by Landesamt für Gesundheit und Soziales (LaGeSo) Berlin.
Human blood samples. Buffy coats were from DRK-Blutspendedienst Nord-Ost and were used for isolation of human T-cell populations as approved by the local ethics committee (Ethikkommission, Ethikausschuss 1, CCM; application no. EA1/095/13).
Antibodies and cell culture reagents. Antibodies and fusion proteins used were as follows: anti-mCD4 (RM4-5), anti-mCD25 (PC6.1), antimCD45RB (16A), anti-mThy1.1 (OX-7), anti-ma 4 b 7 (DATK32) and streptavidin PE-Cy7 (all BD Pharmingen, Franklin Lakes, NJ), antihuman IgG (Jackson Immuno Research, West Grove, PA), antimCCR9 (242503; R&D Systems, Minneapolis, MN), biotinylated antima 4 b 7 (DATK32, anti-mFcgR II/III (2.4G2), anti-mB220 (RA3.6B2), anti-mMac-1 (M1/70.15.11), anti-mCD8 (53-6.7), anti-mCD3 (145.2C11), anti-mCD28 (37.51), anti-OVA-specific mTCR (KJ1.26), anti-mMAdCAM-1 (Meca367), anti-mVCAM-1 (6C7.1), and antimIL4 (all produced in house), anti-hCD3 (UCHT1), anti-hCD4 (OKT4), anti-hCD45RO (UCHL1), anti-hCLA (HECA-452) (from Biolegend, San Diego, CA), and anti-hCD45RA (2H4LDH11LDB9; Beckman-Coulter, Brea, CA). Recombinant murine P-selectin-huIgG fusion protein used for labeling P-selectin ligand (P-lig) was kindly provided by D Vestweber (Münster, Germany). The anti-human a 4 b 7 antibody Act-1 was provided by Millenium at Takeda Pharmaceutical Company (Cambridge, MA) and PE-conjugated in-house. Microbeads were from Miltenyi Biotec (Bergisch Gladbach, Germany). Mouse recombinant IL-2 (rmIL-2), rmIL-12, and rmIFNg (interferon-g) were from R&D Systems, all-trans RA and ovalbumin and cholera toxin were from Sigma-Aldrich, St. Louis, MO, pan-RA receptor antagonist LE540 was from Wako Chemicals (Neuss, Germany). Cell culture was performed in RPMI-1640 (Gibco, Carlsbad, CA and PAA (Cölbe, Germany)) supplemented with 10% fetal calf serum (Sigma). þ T N , pooled erythrocyte-depleted spleen and lymph node cells from BALB/c, C57Bl/6, or Thy1.1 congenic C57Bl/6 mice were stained with anti-mCD4-FITC and anti-mCD25-APC antibodies and depleted of CD25 þ cells using anti-APC microbeads and the AutoMACS magnetic separation system (Miltenyi Biotec). Subsequently, CD25
À cells were positively enriched for CD4 þ T cells using anti-FITC multisort beads. Release reagent and anti-CD62L microbeads were used to obtain CD25 À CD4 þ CD62L high T cells. For the isolation of murine CD4 þ T mem , pooled spleen, peripheral, and mesenteric lymph node cells from 20 to 40 BALB/c exbreeder mice were negatively selected with anti-mCD8, anti-mMac-1, and anti-mB220 antibodies and anti-rat-IgG microbeads. Enriched CD4 þ T cells were labeled with anti-CD45RB FITC and depleted of CD45RB hi cells using anti-FITC microbeads. Subsequently,
þ T cells were sorted by flow cytometry. For methylation analyses, the a 4 b 7 À P-lig þ subset (''inflammation/skin-specific subset'') was sorted as the a 4 b 7 À subset. For isolation of human T cells, peripheral blood mononuclear cells were isolated by density gradient centrifugation using Lymphocyte Separation Medium LSM 1077 (PAA, Cölbe, Germany) from buffy coats. Erythrocytes were lysed in erythrocyte lysis buffer (Buffer EL; Qiagen, Venlo, Niederlande). CD4
þ T-lymphocytes were enriched using CD4 MicroBeads (Miltenyi Biotec). The enriched population was stained and sorted by flow cytometry into four populations:
Purity of the sorted populations was confirmed by flow cytometry and 495%.
In vitro cell cultures. Murine naive CD25
À CD4 þ CD62L high T cells were stimulated on plate-bound anti-mCD3 (1-4 mg ml À 1 ) and antimCD28 (4-8 mg ml À 1 ) antibodies or via irradiated APCs with soluble anti-mCD3 and anti-mCD28 in the presence of rmIL-2 (10 ng ml À 1 ) either under neutral (no further supplements) or under Th1 polarizing conditions (rmIL-12 (5 ng ml À 1 ), rmIFNg (20 ng ml À 1 ), anti-mIL-4 (5 mg ml À 1 )), with or without the addition of RA (1 nM) or LE540 (0.25 mM, to block medium-derived RA). On day 3 of culture, T cells were removed from the stimulus and rested for another 1-3 days. Cells were analyzed for a 4 b 7 expression on the indicated days and restimulated for prolonged culture periods on days 5 and 11. In contrast to T N , ex vivo isolated T mem were stimulated with reduced levels of plate-bound anti-mCD3 (1 mg ml À 1 ) and anti-mCD28 (2 mg ml À 1 ) for 12-16 h and subsequently rested until restimulation.
Analysis of homing receptor expression on adoptively transferred T cells. A total of 1.5-3 Â 10 6 cultured CD4 þ T cells (day 11 of culture) or ex vivo isolated, CFSE-labeled or Thy1.1/2 congenic T mem were injected into the tail vein of recipients. On day 15 or 6 weeks after T-cell transfer, recipient mice were killed and cells from spleen, pLN, and mLNs were stained for CD4, Thy1.1, and a 4 b 7 . At these time points, between 0.12 and 0.05% of the CD4 þ T cells in lymphoid organs were donor-derived.
Generation of vitamin A-deficient mice. Female mice received a vitamin A-deficient (ssniff Spezialdiäten GmbH, Soest, Germany) or control diet 10 days after initial mating (embryonic days 7-10). Offspring was weaned at 3 weeks of age and on diet until 19 weeks of age before transfer of T mem . To verify depletion of vitamin A, CFSElabeled OVA-specific CD4 þ CD62L high T cells from DO11.10 mice were transferred to mice fed vitamin A-reduced or control diet. On day 1 after transfer, mice were immunized with 100 mg OVA protein and 10 mg cholera toxin (both Sigma-Aldrich) by oral gavage. Four days after immunization, a 4 b 7 and CCR9 expression were analyzed on OVA-specific (KJ þ ) mLN cells.
Exclusion of a 4 b 7 þ T mem from GALT. To exclude a 4 b 7 þ T mem from GALT, recipient mice received either rat IgG or anti-MAdCAM-1 (Meca367; 500 mg per mouse) plus anti-VCAM-1 (6C7.1; 200 mg per mouse) antibodies intravenously every 3 days. This treatment started on the day of transfer and was maintained until the analysis of a 4 b 7 expression on day 15.
Generation of luciferase reporter vectors. The Itga4 inserts were amplified by PCR using mouse genomic DNA and the following primers (Eurofins, Hamburg, Germany): Itga4 promoter_fwd: 5 0 -CTG GTGGTAGGTATGTCCTGGGGT-3 0 and Itga4 promoter_rev: 5 0 -CG CTCTTGGTGGAGAACATT-3 0 ; dmr1_fwd: 5 0 -TCAGATTTTGCTA GCCATCCT-3 0 and dmr1_rev: 5 0 -TGCTTCCCACAATTCTAAAA CA-3 0 . PCR fragments for the Itga4 promoter and dmr1 were cloned into the pGL3-basic luciferase reporter vector (Promega, Madison, WI, USA). For the generation of a reporter vector for dmr1 in a CpG-free background, 32 the dmr1 region was inserted into the pCpGL-EF1 vector. 49 Endotoxin-free plasmid DNA for transfection was purified using NucleoBond Xtra Maxi EF (Macherey-Nagel, Düren, Germany).
Luciferase reporter assay. Murine-naive CD25
À CD4 þ CD62L high T cells were stimulated for two days using plate-bound antibodies and polarized towards Th1 as described above. A total of 1 Â 10 6 in vitroinduced C57Bl/6 Th1 cells were transfected with equimolar amounts (3.12 pmol) of the reporter plasmids using the Neon transfection device (Life Technologies, Carlsbad, CA) applying two pulses (voltage: 1,350 V; width: 20 ms). Fifty nanograms of the pRL-CMV vector (Promega) containing the Renilla luciferase cDNA were co-transfected and used as an internal control for transfection efficiency. Cells were cultured for another 24 h with and another 24 h without plate-bound stimulation antibodies. Cells were harvested and luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega). After normalization of firefly activity to Renilla activity, relative firefly activity was normalized to activity of the empty vector.
In vitro methylation of luciferase reporter plasmids. Thirty micrograms of plasmid DNA were incubated with M.SssI (2.5 U mg À 1 DNA) in the presence of 160 mM S-adenosylmethionine for 4 h at 37 1C, with another 160 mM S-adenosylmethionine added after the first 2 h of incubation. Mock-methylated plasmids were treated identically but without the enzyme and S-adenosylmethionine. Plasmid DNA was purified using the NucleoSpinExtract II Kit (Macherey-Nagel). Successful methylation was verified with the methylation-sensitive restriction enzyme HpaII.
DNA methylation analysis by bisulfite sequencing. Bisulfite sequencing for murine and human samples was performed according to Gries et al. 50 (primers in Supplementary Table 1) . Briefly, 300 ng genomic DNA was bisulfite treated using the EZ DNA Methylation Kit (Zymo Research, Irvine, CA, USA). PCRs were performed using primers with a specific 3 0 -portion and a universal 5 0 -portion according to Illumina's specifications (specific portion of primer sequences are listed in Supplementary Table 1) . Amplicons were purified using AGENCOURT Ampurebeads (Beckman/Coulter), diluted, and pooled. Deep sequencing was performed on the Illumina (San Diego, CA) MiSeq according to the manufacturer's protocols aiming at 10,000 reads per amplicon. Reads were processed and aligned using the BiQ Analyzer HT software (http://www.mpi-inf.mpg.de) 51 setting the maximal fraction of unrecognized sites' filter at 0.1.
Statistics.
If not indicated otherwise, data are presented as mean±s.d. or mean±s.e.m.). Significance was determined with Student's t-test, after testing of normal distribution by the Kolmogorov-Smirnov test. Differences were considered statistically significant with *Pr0.05, **Po0.01, and ***Po0.001 Differences in DNA methylation were analyzed by computing differences of permuted methylation levels on each CpG site. Statistical significance was determined by applying onesample, one-tailed Student's t-test on the differences in all CpG in the respective region, with the alternative hypothesis of true methylation difference assumed as 410% or o À 10%. Significance levels (*Pr0.05, **Po0.01, and ***Po0.001) were in accordance with the nonparametric, one-sample Wilcoxon's signed-rank test with similar settings.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
